Healios KK (HLOSF)
0.9929
0.00 (0.00%)
USD |
OTCM |
Apr 30, 16:00
Healios Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 88.00% |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 |
| Date | Value |
|---|---|
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | 85.72% |
| March 31, 2017 | 90.00% |
| December 31, 2016 | 88.53% |
| September 30, 2016 | 88.00% |
| June 30, 2016 | 88.00% |
| March 31, 2016 | 88.32% |
| December 31, 2015 | 87.94% |
| September 30, 2015 | 88.00% |
| June 30, 2015 | 94.12% |
| March 31, 2015 | 88.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
88.00%
Minimum
Jun 2023
88.00%
Maximum
Jun 2023
88.00%
Average
88.00%
Median
Jun 2023
Gross Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 65.85% |
| Nxera Pharma Co Ltd | 76.00% |
| PeptiDream Inc | 48.45% |
| Stemcell Holdings Inc | -- |
| AnGes Inc | 14.39% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -89.76% |
| Return on Assets | -24.13% |
| Return on Invested Capital | -35.44% |
| Profit Margin (Quarterly) | -24.73K% |
| Operating Margin (Quarterly) | -15.44K% |
| Return on Net Operating Assets | -73.95% |